Qinghai Spring Medicinal Resources Technology Co., Ltd.

SHSE:600381 Stock Report

Market Cap: CN¥2.8b

Qinghai Spring Medicinal Resources Technology Management

Management criteria checks 4/4

We currently do not have sufficient information about the CEO.

Key information

Xuefeng Zhang

Chief executive officer

CN¥527.2k

Total compensation

CEO salary percentagen/a
CEO tenure10.4yrs
CEO ownershipn/a
Management average tenure10.4yrs
Board average tenure5.9yrs

Recent management updates

Recent updates

Qinghai Spring Medicinal Resources Technology Co., Ltd.'s (SHSE:600381) 27% Share Price Surge Not Quite Adding Up

Mar 14
Qinghai Spring Medicinal Resources Technology Co., Ltd.'s (SHSE:600381) 27% Share Price Surge Not Quite Adding Up

Optimistic Investors Push Qinghai Spring Medicinal Resources Technology Co., Ltd. (SHSE:600381) Shares Up 25% But Growth Is Lacking

Jan 16
Optimistic Investors Push Qinghai Spring Medicinal Resources Technology Co., Ltd. (SHSE:600381) Shares Up 25% But Growth Is Lacking

There's Reason For Concern Over Qinghai Spring Medicinal Resources Technology Co., Ltd.'s (SHSE:600381) Massive 30% Price Jump

Nov 11
There's Reason For Concern Over Qinghai Spring Medicinal Resources Technology Co., Ltd.'s (SHSE:600381) Massive 30% Price Jump

Qinghai Spring Medicinal Resources Technology Co., Ltd.'s (SHSE:600381) Share Price Is Still Matching Investor Opinion Despite 30% Slump

Jun 24
Qinghai Spring Medicinal Resources Technology Co., Ltd.'s (SHSE:600381) Share Price Is Still Matching Investor Opinion Despite 30% Slump

Qinghai Spring Medicinal Resources Technology Co., Ltd.'s (SHSE:600381) 26% Cheaper Price Remains In Tune With Revenues

May 09
Qinghai Spring Medicinal Resources Technology Co., Ltd.'s (SHSE:600381) 26% Cheaper Price Remains In Tune With Revenues

Qinghai Spring Medicinal Resources Technology Co., Ltd.'s (SHSE:600381) 27% Price Boost Is Out Of Tune With Revenues

Mar 12
Qinghai Spring Medicinal Resources Technology Co., Ltd.'s (SHSE:600381) 27% Price Boost Is Out Of Tune With Revenues

CEO

Xuefeng Zhang (56 yo)

10.4yrs
Tenure
CN¥527,200
Compensation

Mr. Xuefeng Zhang serves as Chairman & GM of Qinghai Spring Medicinal Resources Technology Co., Ltd. since May 15, 2015.

Leadership Team

NamePositionTenureCompensationOwnership
Xuefeng Zhang
Chairman & GM10.4yrsCN¥527.20kno data
Wang Lin
Financial Director & Accounting Supervisor7.4yrsCN¥480.20kno data
Tiepeng Yao
Deputy GM & Director10.8yrsCN¥340.30kno data
Ding Chen
Deputy GM11.5yrsCN¥313.30kno data
Lingxiao Liu
Deputy General Manager10.4yrsCN¥557.30kno data
10.4yrs
Average Tenure
56yo
Average Age

Experienced Management: 600381's management team is seasoned and experienced (10.4 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Xuefeng Zhang
Chairman & GM10.4yrsCN¥527.20kno data
Tiepeng Yao
Deputy GM & Director6.4yrsCN¥340.30kno data
Ding Chen
Deputy GM11.5yrsCN¥313.30kno data
Rong Xiao
Director10.4yrsCN¥60.00kno data
Xuemin Gao
Independent Director5.3yrsCN¥60.00kno data
Bojun Dong
Independent Director5.3yrsCN¥60.00kno data
Junxia Ni
Chair of the Supervisory Board8.4yrsno datano data
Xuan Huang
Supervisor3.4yrsno datano data
Jin Zhang
Supervisor3.4yrsno datano data
Yuqi Song
Independent Director2.4yrsCN¥60.00kno data
5.9yrs
Average Tenure
56.5yo
Average Age

Experienced Board: 600381's board of directors are considered experienced (5.9 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/05 10:37
End of Day Share Price 2025/09/30 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Qinghai Spring Medicinal Resources Technology Co., Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Qi HeHuatai Research